Legato Capital Management LLC Verona Pharma PLC Transaction History
Legato Capital Management LLC
- $761 Million
- Q3 2024
A detailed history of Legato Capital Management LLC transactions in Verona Pharma PLC stock. As of the latest transaction made, Legato Capital Management LLC holds 10,670 shares of VRNA stock, worth $567,857. This represents 0.04% of its overall portfolio holdings.
Number of Shares
10,670
Previous 10,670
-0.0%
Holding current value
$567,857
Previous $154,000
98.7%
% of portfolio
0.04%
Previous 0.02%
Shares
3 transactions
Others Institutions Holding VRNA
# of Institutions
170Shares Held
68.7MCall Options Held
704KPut Options Held
685K-
Perceptive Advisors LLC New York, NY6.32MShares$336 Million4.75% of portfolio
-
Nea Management Company, LLC Timonium, MD5.58MShares$297 Million12.27% of portfolio
-
Ra Capital Management, L.P. Boston, MA5.01MShares$267 Million2.01% of portfolio
-
Lee Ainslie Maverick Capital LTD | Dallas, Tx4.22MShares$224 Million2.52% of portfolio
-
Vivo Capital, LLC Palo Alto, CA3.55MShares$189 Million14.95% of portfolio
About Verona Pharma plc
- Ticker VRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,954,200
- Market Cap $3.24B
- Description
- Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodi...